Tsai Chung-Jyi, Leitzmann Michael F, Willett Walter C, Giovannucci Edward L
Channing Laboratory, Harvard Medical School, Brigham and Women's Hospital, and Harvard School of Public Health, Boston, Massachusetts, USA.
Ann Intern Med. 2004 Oct 5;141(7):514-22. doi: 10.7326/0003-4819-141-7-200410050-00007.
Monounsaturated and polyunsaturated fats act as inhibitors of cholesterol cholelithiasis in animal experiments.
To examine the association between long-term intake of cis unsaturated fats and the incidence of gallstone disease in humans.
Prospective population-based cohort study.
The Health Professional Follow-up Study.
45,756 men, age 40 to 75 years in 1986, who were free of gallstone disease.
Consumption of cis unsaturated fats was assessed starting in 1986 as part of the 131-item semi-quantitative food-frequency questionnaires. Questionnaires were mailed to participants every 2 years. The main outcome measure was self-reported newly diagnosed symptomatic gallstone disease.
During 14 years of follow-up, 2323 new cases of gallstone disease were documented. After adjustment for age and other potential risk factors, the relative risk for gallstone disease among men in the highest quintile of dietary intake of cis unsaturated fats compared with men in the lowest quintile was 0.82 (95% CI, 0.69 to 0.96; P for trend = 0.006). The relative risk among men in the highest quintile of polyunsaturated fat consumption compared with men in the lowest quintile was 0.84 (CI, 0.73 to 0.96; P for trend = 0.01), and the relative risk among men in the highest quintile of monounsaturated fat consumption compared with men in the lowest quintile was 0.83 (CI, 0.70 to 1.00; P for trend = 0.01).
Outcomes were restricted to men with cholecystectomy or diagnostically confirmed but unremoved symptomatic gallstones.
A high intake of polyunsaturated and monounsaturated fats in the context of an energy-balanced diet is associated with a reduced risk for gallstone disease in men. For definitions of terms used in the text, see Glossary.
在动物实验中,单不饱和脂肪和多不饱和脂肪可作为胆固醇性胆结石的抑制剂。
研究长期摄入顺式不饱和脂肪与人类胆结石疾病发病率之间的关联。
基于人群的前瞻性队列研究。
健康专业人员随访研究。
1986年年龄在40至75岁之间、无胆结石疾病的45756名男性。
从1986年开始,作为131项半定量食物频率问卷的一部分,评估顺式不饱和脂肪的摄入量。问卷每两年邮寄给参与者一次。主要结局指标是自我报告的新诊断出的有症状胆结石疾病。
在14年的随访期间,记录了2323例新的胆结石疾病病例。在对年龄和其他潜在风险因素进行调整后,饮食中顺式不饱和脂肪摄入量最高五分位数的男性与最低五分位数的男性相比,患胆结石疾病的相对风险为0.82(95%可信区间,0.69至0.96;趋势P值 = 0.006)。多不饱和脂肪摄入量最高五分位数的男性与最低五分位数的男性相比,相对风险为0.84(可信区间,0.73至0.96;趋势P值 = 0.01),单不饱和脂肪摄入量最高五分位数的男性与最低五分位数的男性相比,相对风险为0.83(可信区间,0.70至1.00;趋势P值 = 0.01)。
研究结果仅限于接受胆囊切除术或经诊断确认但未切除的有症状胆结石的男性。
在能量平衡饮食的情况下,高摄入多不饱和脂肪和单不饱和脂肪与男性胆结石疾病风险降低有关。文中所用术语的定义见词汇表。